CHEMBL4226613
Ligand Summary
Name: (3S,6S,9S,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S)-39-((2S,5S,8S,11S,14S,17S,20S,23S,24R)-11-((1H-indol-3-yl)methyl)-20-(2-amino-2-oxoethyl)-5-sec-butyl-23-carbamoyl-24-hydroxy-14-isobutyl-8-methyl-17-(2-(methylthio)ethyl)-3,6,9,12,15,18,21-heptaoxo-1-phenyl-4,7,10,13,16,19,22-heptaazapentacosan-2-ylcarbamoyl)-3-((2S,5S,8S,11S,17S,20S,23S)-23-amino-17-(3-amino-3-oxopropyl)-8-benzyl-5,11-bis((R)-1-hydroxyethyl)-2,20-bis(hydroxymethyl)-24-(1H-imidazol-5-yl)-4,7,10,13,16,19,22-heptaoxo-3,6,9,12,15,18,21-heptaazatetracosanamido)-27-(3-amino-3-oxopropyl)-12,36-bis(4-aminobutyl)-24-(2-carboxyethyl)-21-(carboxymethyl)-6,15-bis(4-hydroxybenzyl)-9-(hydroxymethyl)-18-isobutyl-30,33-dimethyl-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxo-5,8,11,14,17,20,23,26,29,32,35,38-dodecaazadotetracontane-1,42-dioic acid
PubChem: 145969945
ChEMBL: CHEMBL4226613
LyCHI: YQU81HAA35VW
Target Activities
3 Activities
Items per page:
1 – 3 of 3
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
EC50 | ||||||
EC50 | ||||||
EC50 | ||||||